Lupin Pharmaceuticals Inc. recalls Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL (wh
Recalled April 21, 2021 · FDA recall D-0332-2021 · Lupin Pharmaceuticals
Hazard
Superpotent Drug · FDA Class II
Units
a) 6,816 bottles; b) 3,960 bottles and c) 7,038 bottles
Sold at
Nationwide in the USA and Puerto Rico
Description
Superpotent Drug
Product
Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL (when mixed) bottles (NDC 68180-402-02); and c) 100 mL (when mixed) bottles (NDC 68180-402-03); Rx only, Manufactured for: Lupin Pharmaceutical, Inc., Baltimore, MD 21202; Manufactured by: Lupin Limited, Mandideep 462 046, India.
Manufacturer(s)
Lupin Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →